Ibn initiates coverage of soligenix inc.

Austin, texas, march 25, 2025 (globe newswire) -- via ibn – soligenix inc. (nasdaq: sngx), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases with an unmet medical need, has selected ibn, a multifaceted financial news and publishing company serving private and public entities, to spearhead its corporate communications efforts.
SNGX Ratings Summary
SNGX Quant Ranking